Invention Grant
- Patent Title: Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
-
Application No.: US14918655Application Date: 2015-10-21
-
Publication No.: US09725450B2Publication Date: 2017-08-08
- Inventor: Steven Clareen , Veronique Plantevin-Krenitsky , Moorthy Palanki , Yoshitaka Satoh
- Applicant: Signal Pharmaceuticals, LLC
- Applicant Address: US CA San Diego
- Assignee: Signal Pharmaceuticals, LLC
- Current Assignee: Signal Pharmaceuticals, LLC
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: C07D473/32
- IPC: C07D473/32 ; A61K31/52 ; A61P35/00

Abstract:
Provided herein are Aminopurine Compounds having the following structure: wherein R1, R2 and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion injury, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension or a condition treatable or preventable by inhibition of the JNK pathway comprising administering an effective amount of an Aminopurine Compound to a patient in need thereof.
Public/Granted literature
- US20160039822A1 HALOARYL SUBSTITUTED AMINOPURINES, COMPOSITIONS THEREOF,AND METHODS OF TREATMENT THEREWITH Public/Granted day:2016-02-11
Information query